Ascendis Pharma News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

16.10.17	Ascendant Resources Inc. Opens the Market (PR Newswire)
16.10.17	Ascendant Resources Inc. Opens the Market (PR Newswire)
12.10.17	Prevost(MD) ouvre de nouveaux centres de service en Amérique du Nord (PR Newswire)
27.09.17	IIROC Trade Resumption - DHX.A (PR Newswire)
27.09.17	AKBA Hits New 52-week High, PMD Launches Hair Test, Mateon Runs Out Of FOCUS (RTTNews)
05.09.17	OTC Markets Group Welcomes Ascendant Resources to OTCQX (PR Newswire)
29.06.17	Gainers & Losers Of June 28: RARX, ESPR, ASND, FLKS, ALDR... (RTTNews)
11.05.17	Ascendis Pharma A/S Announces First Quarter 2017 Financial Results Conference Call on May 23 (PR Newswire)
28.04.17	Ascendis Pharma A/S Announces Upcoming Investor Presentations (PR Newswire)
03.04.17	Ascendis Pharma A/S Showcases New Data on Rare Disease Product Pipeline at ENDO 2017 (PR Newswire)
03.04.17	Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise (RTTNews)
31.03.17	Ascendis Pharma A/S Announces Updated Time for April 3 Conference Call to Review ENDO 2017 Data (PR Newswire)
23.03.17	Ascendis Pharma A/S Announces Conference Call and Webcast to Review Data at ENDO 2017 on April 3 (PR Newswire)
22.03.17	Ascendis Pharma A/S Reports Full Year 2016 Financial Results (PR Newswire)
10.03.17	Ascendis Pharma A/S Announces Year-End 2016 Financial Results Conference Call on March 22 (PR Newswire)
28.02.17	Ascendis Pharma A/S Announces Multiple Poster Presentations at ENDO 2017 (PR Newswire)
16.02.17	Ascendis Pharma A/S Announces Publication of Comprehensive Results from Randomized, Active-Controlled Phase 2 Trial of Once-Weekly TransCon Growth Hormone in Pediatric Patients (PR Newswire)
07.02.17	Ascendis Pharma A/S Announces Presentation at the LEERINK Partners 6th Annual Global Healthcare Conference on February 15th (PR Newswire)
30.11.16	Ascendis Pharma A/S Reports Third Quarter 2016 Financial Results (PR Newswire)
30.11.16	Ascendis Pharma A/S Reports Third Quarter 2016 Financial Results (PR Newswire)
30.07.15	Towering Or Stunted? Ascendis Pharma Will Reveal It Today... (RTTNews)
29.04.15	ASND Descends, IG Results Disappoint, NVGN Back On Track, All Eyes On ONCE (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V